CoChat

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China

Open access

Abstract

Candida parapsilosis is becoming a predominant non-albicans cause of invasive candidiasis (IC). Echinocandins are the preferred choice for IC treatment and prophylaxis. Resistance to echinocandins in C. parapsilosis has emerged in several countries, but little is known about the susceptibility profile in China or about mechanisms of resistance. Here, we investigated the echinocandin susceptibilities of 2523 C. parapsilosis isolates collected from China and further explored the resistance mechanism among echinocandin-resistant isolates. Anidulafungin exhibited the highest MICs (MIC50/90, 1 and 2 µg/mL; GM, 0.948 µg/mL), while caspofungin showed better activity (0.5 and 1 µg/mL; 0.498 µg/mL). Significantly higher echinocandin MICs were observed among blood-derived isolates compared to others, especially for caspofungin (GM, 1.348 µg/mL vs 0.478 µg/mL). Isolates from ICU and surgical wards also showed higher MICs. Twenty isolates showed intermediate phenotypes for at least one echinocandin. One was resistant to all three echinocandins, fluconazole and voriconazole, which caused breakthrough IC during long-term exposure to micafungin. WGS revealed this isolate carried a mutation S656P in hotspot1 region of Fks1. Bioinformatics analyses suggested that this mutation might lead to an altered protein conformation. CRISPR Cas9-mediated introduction of this mutation into a susceptible reference C. parapsilosis strain increased MICs of all echinocandins 64-fold, with similar results found in the subspecies, C. orthopsilosis and C. metapsilosis. This is the first report of a multi-azole resistant and pan-echinocandin resistant C. parapsilosis isolate, and the identification of a FKS1S656P conferring pan-echinocandin resistance. Our study underscores the necessity of rigorous management of antifungal use and of monitoring for antifungal susceptibility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/22221751.2022.2153086

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Profile of C. parapsilosis susceptibility to echinocandins. (A) Distribution of susceptibility to three echinocandins of 2523 clinical isolates from China collected by CHIF-NET 2015–2019 programme. (B and C) Susceptibility differences of isolates regarding different samples (B), and hospital departments (C). Geometric mean of the MIC (GM) values are shown in the boxes; differences between each two groups were analyzed, while only significant differences compared to the “others” group are shown in the figure. AND, anidulafungin; CAS, caspofungin; MF, micafungin. *, P < 0.05; ****, P < 0.0001.
Figure 1. Profile of C. parapsilosis susceptibility to echinocandins. (A) Distribution of susceptibility to three echinocandins of 2523 clinical isolates from China collected by CHIF-NET 2015–2019 programme. (B and C) Susceptibility differences of isolates regarding different samples (B), and hospital departments (C). Geometric mean of the MIC (GM) values are shown in the boxes; differences between each two groups were analyzed, while only significant differences compared to the “others” group are shown in the figure. AND, anidulafungin; CAS, caspofungin; MF, micafungin. *, P < 0.05; ****, P < 0.0001.CC BY · PubMed Central
Figure 2. Strain characteristics of the pan-echinocandin resistant C. parapsilosis clinical isolate. (A) In vitro susceptibility to nine common antifungal drugs. The dashed red line indicates the breakpoints for defining drug resistance or cut-off values for non-wild type. (B) Transmembrane helix predictions for Fks1 of C. parapsilosis. The location of the amino acid 656 is labelled.
Figure 2. Strain characteristics of the pan-echinocandin resistant C. parapsilosis clinical isolate. (A) In vitro susceptibility to nine common antifungal drugs. The dashed red line indicates the breakpoints for defining drug resistance or cut-off values for non-wild type. (B) Transmembrane helix predictions for Fks1 of C. parapsilosis. The location of the amino acid 656 is labelled.CC BY · PubMed Central
Figure 3. Structural and functional effect of the S656P substitution in Fks1. (A) The predicted structural model for the variants of the Fks1 protein (amino acids 400∼900), the S656P substitution would result in the helix-to-coil transition, disrupting conformation of this ɑ-helix. (B) Echinocandin MICs for susceptible C. parapsilosis strain ATCC 22019 and its mutant harbouring Fks1 S656P, and the pan-echinocandin resistant clinical isolate TJ1197 and its mutant with WT of Fks1. (C) Changes in expression of the FKS1 and CHS3 genes in response to micafungin at the sub-MICs. (D) Echinocandin MICs for susceptible C. orthopsilosis ATCC 96139, C. metapsilosis ATCC 96143, and their mutants carrying homologous modifications, S649P and S656P, respectively. Dashed red lines indicate the breakpoints for defining drug resistance or cut-off values for non-wild type. AND, anidulafungin; CAS, caspofungin; MF, micafungin. **, P < 0.01; ***, P < 0.001.
Figure 3. Structural and functional effect of the S656P substitution in Fks1. (A) The predicted structural model for the variants of the Fks1 protein (amino acids 400∼900), the S656P substitution would result in the helix-to-coil transition, disrupting conformation of this ɑ-helix. (B) Echinocandin MICs for susceptible C. parapsilosis strain ATCC 22019 and its mutant harbouring Fks1 S656P, and the pan-echinocandin resistant clinical isolate TJ1197 and its mutant with WT of Fks1. (C) Changes in expression of the FKS1 and CHS3 genes in response to micafungin at the sub-MICs. (D) Echinocandin MICs for susceptible C. orthopsilosis ATCC 96139, C. metapsilosis ATCC 96143, and their mutants carrying homologous modifications, S649P and S656P, respectively. Dashed red lines indicate the breakpoints for defining drug resistance or cut-off values for non-wild type. AND, anidulafungin; CAS, caspofungin; MF, micafungin. **, P < 0.01; ***, P < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 63

Metadata

Authors
Ning, Y., Xiao, M., Perlin, D. S., Zhao, Y., Lu, M., Li, Y., Luo, Z., Dai, R., Li, S., Xu, J., Liu, L., He, H., Liu, Y., Li, F., Guo, Y., Chen, Z., Xu, Y., Sun, T., & Zhang, L.
Affiliations
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • Hackensack Meridian Health (US)
  • Zhejiang Chinese Medical University (CN)
  • Affiliated Hospital of Qingdao University (CN)
  • Second Military Medical University (CN)
  • First Hospital of China Medical University (CN)
  • Liaoning Provincial People's Hospital (CN)
  • Tongji Hospital (CN)
Corresponding author
  • Chen, Zhongju
  • Xu, Yingchun
  • Sun, Tianshu
  • Zhang, Li
Venue
Emerging Microbes & Infections
Published
2022-12-24
Volume
12
Issue
1
Pages
2153086-2153086
ISSN
2222-1751 (ISSN-L)
OpenAlex
W4310184775
Cited by
63
References
54
Citations by year
2026: 8 · 2025: 24 · 2024: 16 · 2023: 13 · 2022: 2
FWCI
6.71
Type
journal article
Language
en
Open access
Locations
  • Emerging Microbes & Infections (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2021-I2M-1-044)
  • National High Level Hospital Clinical Research Funding (2022-PUMCH-A-137)
  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Beijing Key Clinical Specialty for Laboratory Medicine-Excellent Project
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
Candida parapsilosis, echinocandin resistance, candidemia, invasive candidiasis, caspofungin, anidulafungin, micafungin, antifungal susceptibility, CRISPR/Cas9 mutagenesis, Candida orthopsilosis, Candida metapsilosis
MeSH terms
Candida parapsilosis, Caspofungin, Antifungal Agents, Candidiasis, China, Humans, Microbial Sensitivity Tests, Drug Resistance, Fungal, Echinocandins, Candidemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. https://app.cochat.ai/papers/10.1080/22221751.2022.2153086
The paper
Ning, Y., Xiao, M., Perlin, D. S., Zhao, Y., Lu, M., Li, Y., Luo, Z., Dai, R., Li, S., Xu, J., Liu, L., He, H., Liu, Y., Li, F., Guo, Y., Chen, Z., Xu, Y., Sun, T., & Zhang, L. (2023). Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. Emerging Microbes & Infections. https://doi.org/10.1080/22221751.2022.2153086

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.